Updated Coverage – PreveCeutical Medical, Inc. (PRVCF, PREV)

Early stage biotechnology company PreveCeutical Medical (PRVCF:  OTC, PREV:  CN) has made considerable progress with an ambitious research pipeline focused on preventative and curative medicines.  The Company has claimed several achievements in recent months, moving projects “closer to goal.’ We have had high hopes for the Company in 2018, and so far we have not […]

Read More

Updated Coverage – PreveCeutical Medical (PRVCF, PREV)

PreveCeutical Medical is an early stage biotech with ample risk in a nascent development pipeline.  Nonetheless, the Company has made progress with its development projects, demonstrating the ability of the scientific team to execute on the R&D agenda. Highest priority on the Company’s agenda is a non-opioid pain treatment compound based on cannabinoids and administered […]

Read More

Updated Coverage – Westwater Resources (WWR)

We have updated coverage of energy materials developer Westwater Resources (WWR) following report of financial resulting in the quarter ending March 2018, and other developments in the Company’s asset portfolio. In April 2018, Westwater completed the previously announced acquisition of Alabama Graphite.  Management confirmed plans to develop what could be the first domestic source of […]

Read More